The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue.
Authors
Ryan, JamesCurran, Catherine E
Hennessy, Emer
Newell, John
Morris, John C
Kerin, Michael J
Dwyer, Roisin M
Affiliation
Division of Surgery, School of Medicine, National University of Ireland Galway, Galway, Ireland.Issue Date
2011-01MeSH
Breast NeoplasmsEstradiol
Female
Fibroadenoma
Gene Expression Regulation, Neoplastic
Humans
Mammary Glands, Human
Symporters
Thyroid Hormones
Thyroxine
Tretinoin
Metadata
Show full item recordCitation
The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. 2011, 6 (1):e16023 PLoS ONEJournal
PloS oneDOI
10.1371/journal.pone.0016023PubMed ID
21283523Abstract
The presence, relevance and regulation of the Sodium Iodide Symporter (NIS) in human mammary tissue remains poorly understood. This study aimed to quantify relative expression of NIS and putative regulators in human breast tissue, with relationships observed further investigated in vitro.Human breast tissue specimens (malignant n = 75, normal n = 15, fibroadenoma n = 10) were analysed by RQ-PCR targeting NIS, receptors for retinoic acid (RARα, RARβ), oestrogen (ERα), thyroid hormones (THRα, THRβ), and also phosphoinositide-3-kinase (PI3K). Breast cancer cells were treated with Retinoic acid (ATRA), Estradiol and Thyroxine individually and in combination followed by analysis of changes in NIS expression.
The lowest levels of NIS were detected in normal tissue (Mean(SEM) 0.70(0.12) Log(10) Relative Quantity (RQ)) with significantly higher levels observed in fibroadenoma (1.69(0.21) Log(10)RQ, p<0.005) and malignant breast tissue (1.18(0.07) Log(10)RQ, p<0.05). Significant positive correlations were observed between human NIS and ERα (r = 0.22, p<0.05) and RARα (r = 0.29, p<0.005), with the strongest relationship observed between NIS and RARβ (r = 0.38, p<0.0001). An inverse relationship between NIS and PI3K expression was also observed (r = 0.21, p<0.05). In vitro, ATRA, Estradiol and Thyroxine individually stimulated significant increases in NIS expression (range 6-16 fold), while ATRA and Thyroxine combined caused the greatest increase (range 16-26 fold).
Although NIS expression is significantly higher in malignant compared to normal breast tissue, the highest level was detected in fibroadenoma. The data presented supports a role for retinoic acid and estradiol in mammary NIS regulation in vivo, and also highlights potential thyroidal regulation of mammary NIS mediated by thyroid hormones.
Item Type
ArticleLanguage
enISSN
1932-6203ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0016023
Scopus Count
Collections
Related articles
- MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.
- Authors: Khan S, Wall D, Curran C, Newell J, Kerin MJ, Dwyer RM
- Issue date: 2015 May 2
- Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
- Authors: Willhauck MJ, O Kane DJ, Wunderlich N, Göke B, Spitzweg C
- Issue date: 2011 Jan
- Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma.
- Authors: Berger F, Unterholzner S, Diebold J, Knesewitsch P, Hahn K, Spitzweg C
- Issue date: 2006 Nov 3
- Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
- Authors: Lim SJ, Paeng JC, Kim SJ, Kim SY, Lee H, Moon DH
- Issue date: 2007 Mar
- Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
- Authors: Unterholzner S, Willhauck MJ, Cengic N, Schütz M, Göke B, Morris JC, Spitzweg C
- Issue date: 2006 Jan